A potent anti-HIV-1 gene therapy agent in a humanised mouse model

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1085359

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

We have shown that a synthetic protein called Nullbasic can protect human cells from becoming infected by the AIDS virus, HIV-1. In this project a gene therapy approach will be used to test if a human immune system modified to contain Nullbasic is protected from HIV-1 in an animal model.

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $1,147,139.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Medical Virology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

animal model | antiviral therapy | gene therapy | human immunodeficiency virus (HIV) | virology

Related Links